Creating Chinese language versions of a key Alzheimer's assessment tool
Chinese language versions of the National Alzheimer's Coordinating Center's Uniform Data Set version 4: a linguistic and cultural adaptation study
This study is working to create Mandarin and Cantonese versions of an Alzheimer's assessment tool to help older Chinese Americans get more accurate diagnoses and better care, while also making sure the tool fits their cultural needs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11076362 on NIH RePORTER |
What this research studies
This research focuses on adapting the National Alzheimer's Coordinating Center's Uniform Data Set to be culturally and linguistically appropriate for older Chinese Americans. It aims to develop Mandarin and Cantonese versions of the assessment tool to improve the accuracy of Alzheimer's disease diagnoses in this population. The study will address limitations in existing translations and create normative data to support better diagnosis and treatment. By involving community members in the adaptation process, the research seeks to ensure that the assessments are relevant and effective.
Who could benefit from this research
Good fit: Ideal candidates for this research are older Chinese Americans who may be experiencing symptoms of Alzheimer's disease or related dementias.
Not a fit: Patients who do not speak Mandarin or Cantonese or who are not part of the older Chinese American community may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of Alzheimer's disease for older Chinese Americans.
How similar studies have performed: Similar research efforts have shown success in adapting assessment tools for diverse populations, indicating a promising approach for this study.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Li, Clara — Icahn School of Medicine at Mount Sinai
- Study coordinator: Li, Clara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.